Microalbuminuria and Allopurinol in Type 1 Diabetes

Summary

The objective is to determine if lowering serum uric acid by means of allopurinol in the course of kidney disease may be effective in preventing or improving albuminuria and renal function in Type 1 Diabetic patients. The study is a double blinded, randomised, placebo-controlled cross-over clinical trial.

Timeline

Start

2014-09

Primary completion

2016-08-10

Completion

2017-09-20

Drugs

Indications